Cargando…
Personalized medicine and atrial fibrillation: will it ever happen?
Atrial fibrillation (AF) is a common arrhythmia of substantial public health importance. Recent evidence demonstrates a heritable component underlying AF, and genetic discoveries have identified common variants associated with the arrhythmia. Ultimately one hopes that the consideration of genetic va...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568716/ https://www.ncbi.nlm.nih.gov/pubmed/23210687 http://dx.doi.org/10.1186/1741-7015-10-155 |
| _version_ | 1782258804118781952 |
|---|---|
| author | Lubitz, Steven A Ellinor, Patrick T |
| author_facet | Lubitz, Steven A Ellinor, Patrick T |
| author_sort | Lubitz, Steven A |
| collection | PubMed |
| description | Atrial fibrillation (AF) is a common arrhythmia of substantial public health importance. Recent evidence demonstrates a heritable component underlying AF, and genetic discoveries have identified common variants associated with the arrhythmia. Ultimately one hopes that the consideration of genetic variation in clinical practice may enhance care and improve health outcomes. In this review we explore areas of potential clinical utility in AF management including those relating to pharmacogenetics and risk prediction. |
| format | Online Article Text |
| id | pubmed-3568716 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35687162013-02-12 Personalized medicine and atrial fibrillation: will it ever happen? Lubitz, Steven A Ellinor, Patrick T BMC Med Minireview Atrial fibrillation (AF) is a common arrhythmia of substantial public health importance. Recent evidence demonstrates a heritable component underlying AF, and genetic discoveries have identified common variants associated with the arrhythmia. Ultimately one hopes that the consideration of genetic variation in clinical practice may enhance care and improve health outcomes. In this review we explore areas of potential clinical utility in AF management including those relating to pharmacogenetics and risk prediction. BioMed Central 2012-12-04 /pmc/articles/PMC3568716/ /pubmed/23210687 http://dx.doi.org/10.1186/1741-7015-10-155 Text en Copyright ©2012 Lubitz and Ellinor; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Minireview Lubitz, Steven A Ellinor, Patrick T Personalized medicine and atrial fibrillation: will it ever happen? |
| title | Personalized medicine and atrial fibrillation: will it ever happen? |
| title_full | Personalized medicine and atrial fibrillation: will it ever happen? |
| title_fullStr | Personalized medicine and atrial fibrillation: will it ever happen? |
| title_full_unstemmed | Personalized medicine and atrial fibrillation: will it ever happen? |
| title_short | Personalized medicine and atrial fibrillation: will it ever happen? |
| title_sort | personalized medicine and atrial fibrillation: will it ever happen? |
| topic | Minireview |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568716/ https://www.ncbi.nlm.nih.gov/pubmed/23210687 http://dx.doi.org/10.1186/1741-7015-10-155 |
| work_keys_str_mv | AT lubitzstevena personalizedmedicineandatrialfibrillationwilliteverhappen AT ellinorpatrickt personalizedmedicineandatrialfibrillationwilliteverhappen |